We have the tools – now we need the money
Treatment as prevention: what are the next steps?
Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids
Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks
South Africa's PMTCT programme reduces mother-to-child transmission to under 4%
Daily aciclovir slows HIV disease progression and reduces viral load
Viral suppression reduces HIV risk despite more sex and 'condom fatigue' in patients starting treatment in Cameroon
Testing project using social networks in rural Tanzania effective in identifying people with undiagnosed infection
Colore locale
